会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 92. 发明申请
    • SOLID OXIDE FUEL CELL SYSTEMS
    • 固体氧化物燃料电池系统
    • WO2009148505A2
    • 2009-12-10
    • PCT/US2009/003110
    • 2009-05-20
    • CORNING INCORPORATEDBADDING, Michael, E.BOUTON, William, J.CHEN, PengGREGORSKI, Steven, J.
    • BADDING, Michael, E.BOUTON, William, J.CHEN, PengGREGORSKI, Steven, J.
    • H01M8/02H01M8/04H01M8/24
    • H01M8/2475F28D9/0037F28D9/0043F28F3/12F28F21/08F28F2265/26H01M8/0273H01M8/04014H01M8/04074H01M8/04104H01M8/04268H01M8/242H01M8/2425H01M8/2483
    • According to one embodiment of the present invention a fuel cell system comprises: (i) a plurality of fuel cell packets, each packet comprising at least one fuel inlet, at least one fuel outlet, a frame, and two multi-cell fuel cell devices, the fuel cell devices situated such that an anode side of one fuel cell device faces an anode side of another fuel cell device, and the two fuel cell devices, in combination, at least partially form a fuel chamber connected to the fuel inlet and the fuel outlet; (ii) a plurality of heat exchange packets, each packet comprising at least one oxidant inlet, at least one oxidant outlet, and an internal oxidant chamber connected to the at least one oxidant inlet and the least one oxidant outlet; the heat exchange packets being parallel to and interspersed between the fuel cell packets, such that the heat exchange packets face the fuel cell packets and form, at least in part, a plurality of cathode reaction chambers between the heat exchange packets and the fuel cell packets; (iii) a housing supporting and enclosing the fuel packets and the heat exchange packets; (iv) an oxidant inlet plenum operatively connected to oxidant inlets of the heat exchange packets; (v) an oxidant exhaust plenum operatively connected to the cathode reaction chambers; (vi) an inlet fuel manifold connected to fuel inlets of the fuel cell packets; and (vii) an exhaust fuel manifold connected to the fuel outlets of the fuel cell packets.
    • 根据本发明的一个实施例,燃料电池系统包括:(i)多个燃料电池组,每个分组包括至少一个燃料入口,至少一个燃料出口,框架和两个多单元燃料电池装置 燃料电池装置被设置为使得一个燃料电池装置的阳极侧面对另一个燃料电池装置的阳极侧,并且两个燃料电池装置组合至少部分地形成连接到燃料入口的燃料室和 燃料出口 (ii)多个热交换包,每个包包含至少一个氧化剂入口,至少一个氧化剂出口和连接到所述至少一个氧化剂入口和所述至少一个氧化剂出口的内部氧化剂室; 所述热交换包平行于并分散在所述燃料电池包之间,使得所述热交换包面向所述燃料电池包并且至少部分地形成所述热交换包与所述燃料电池包之间的多个阴极反应室 ; (iii)支撑和封闭燃料包和热交换包的壳体; (iv)可操作地连接到热交换包的氧化剂入口的氧化剂入口增压室; (v)可操作地连接到阴极反应室的氧化剂排气室; (vi)连接到燃料电池组的燃料入口的入口燃料歧管; 和(vii)连接到燃料电池组件的燃料出口的排气燃料歧管。
    • 93. 发明申请
    • ACK/NACK TRANSMISSION ON PUCCH IN LTE-ATDD WITH NXPDCCH STRUCTURE
    • 具有NXPDCCH结构的LTE-ATDD中的PUCCH上的ACK / NACK传输
    • WO2009118621A2
    • 2009-10-01
    • PCT/IB2009/005075
    • 2009-03-25
    • NOKIA CORPORATIONCHE, Xiang GuangCHEN, PengKOLDING, Troels EmilFREDERIKSEN, Frank
    • CHE, Xiang GuangCHEN, PengKOLDING, Troels EmilFREDERIKSEN, Frank
    • H04L1/18
    • H04L1/003H04L1/0025H04L1/1621H04L1/1854H04L5/0053
    • Systems and methods are provided for enabling different "bundling" methods for downlink transmissions and provide different interpretations of the acknowledgement/negative- acknowledgement bit. A user equipment is configured so that it commonly acknowledges all downlink transmission time intervals within a bundle so that if one packet is determined to be erroneous, all packets in that bundle will be retransmitted. Additionally, the systems and methods are implemented by allowing an interpretation to be applied to the uplink acknowledgement/negative-acknowledgement field such that the user equipment is able to divide bundled downlink packets into smaller windows in Long Term Evolution (LTE) Release 8 time division duplex (TDD) mode. In LTE Advanced (LTE-A) TDD mode, various embodiments provide bundling within the time domain, within the frequency domain, and within a hybrid time- frequency domain. Furthermore, enhanced channel selection methods are also provided in support of the above-mentioned bundling methods in accordance with various embodiments.
    • 提供的系统和方法用于实现用于下行链路传输的不同的“捆绑”方法,并提供对确认/否定确认位的不同解释。 用户设备被配置为使得它通常确认束内的所有下行链路传输时间间隔,使得如果确定一个分组是错误的,则该分组中的所有分组将被重传。 另外,通过允许将解释应用于上行链路确认/否定确认字段来实现系统和方法,使得用户设备能够在长期演进(LTE)版本8时分中将分组的下行链路分组划分为更小的窗口 双工(TDD)模式。 在LTE高级(LTE-A)TDD模式中,各种实施例在时域内,频域内和混合时频域内提供捆绑。 此外,还提供了增强的信道选择方法,以支持根据各种实施例的上述捆绑方法。
    • 97. 发明申请
    • METHOD AND SYSTEM FOR THE PREDICTION OF CARDIAC ARRHYTHMIAS
    • 心脑血管病预后的方法与系统
    • WO2006004850B1
    • 2007-01-11
    • PCT/US2005023142
    • 2005-06-29
    • CEDARS SINAI MEDICAL CENTERCHEN PENG-SHENG
    • CHEN PENG-SHENG
    • A61B5/04A61B5/02A61N1/00A61N1/18
    • A61B5/04001A61N1/36585A61N1/37258A61N1/3962
    • Methods and systems are provided for determining an increased likelihood of the occurrence of a cardiac arrhythmia in a patient. The methods and systems comprise monitoring the sympathetic neural discharges of a patient from the left stellate ganglion, the thoracic ganglia, or both, and detecting increases in the sympathetic neural discharges. The methods and systems may further comprise delivering anti-arrhythmic therapy to the patient in response to a detected increase in the sympathetic neural discharge, such as delivering one or more pharmacological agents; stimulating myocardial hyperinnervation in the sinus node and right ventricle of the heart of the patient; and applying cardiac pacing, cardioversion or defibrillation shocks. Pharmacologic agents which may be used in connection with the delivery of anti-arrhythmic therapy include those which are known to exert anti-arrhythmic effect and anti-convulsant agents, such as phenytoin, carbamazepine, valproate, and phenobarbitone.
    • 提供了用于确定患者心律失常发生的可能性增加的方法和系统。 方法和系统包括监测来自左星状神经节,胸廓神经节或两者的患者的交感神经放电,并检测交感神经放电的增加。 方法和系统可以进一步包括响应于检测到的交感神经排泄物的增加,例如递送一种或多种药理学试剂,向患者递送抗心律失常疗法; 刺激患者心脏的窦房结和右心室的心肌超调; 并应用心脏起搏,心脏复律或除颤电击。 可用于递送抗心律不齐治疗的药理学试剂包括已知能发挥抗心律不齐作用的药物剂和抗惊厥药如苯妥英,卡马西平,丙戊酸酯和苯巴比妥。
    • 100. 发明申请
    • METHOD AND SYSTEM FOR THE PREDICTION OF CARDIAC ARRHYTHMIAS
    • 心脑血管病预防的方法与系统
    • WO2006004850A2
    • 2006-01-12
    • PCT/US2005023142
    • 2005-06-29
    • CEDARS SINAI MEDICAL CENTERCHEN PENG-SHENG
    • CHEN PENG-SHENG
    • A61N1/362A61B5/0402
    • A61B5/04001A61N1/36585A61N1/37258A61N1/3962
    • Methods and systems are provided for determining an increased likelihood of the occurrence of a cardiac arrhythmia in a patient. The methods and systems comprise monitoring the sympathetic neural discharges of a patient from the left stellate ganglion, the thoracic ganglia, or both, and detecting increases in the sympathetic neural discharges. The methods and systems may further comprise delivering anti-arrhythmic therapy to the patient in response to a detected increase in the sympathetic neural discharge, such as delivering one or more pharmacological agents; stimulating myocardial hyperinnervation in the sinus node and right ventricle of the heart of the patient; and applying cardiac pacing, cardioversion or defibrillation shocks. Pharmacologic agents which may be used in connection with the delivery of anti-arrhythmic therapy include those which are known to exert anti-arrhythmic effect and anti-convulsant agents, such as phenytoin, carbamazepine, valproate, and phenobarbitone.
    • 提供了用于确定患者心律失常发生的可能性增加的方法和系统。 方法和系统包括监测来自左星状神经节,胸廓神经节或两者的患者的交感神经放电,并检测交感神经放电的增加。 方法和系统可以进一步包括响应于检测到的交感神经排泄物的增加,例如递送一种或多种药理学试剂,向患者递送抗心律失常疗法; 刺激患者心脏的窦房结和右心室的心肌超调; 并应用心脏起搏,心脏复律或除颤电击。 可用于递送抗心律不齐治疗的药理学试剂包括已知能发挥抗心律不齐作用的药物剂和抗惊厥药如苯妥英,卡马西平,丙戊酸酯和苯巴比妥。